Erlotinib lactam impurity

Cat. No.: HY-W002950 Pureza: 98.50%: Ficha de datos
COA

SDS
Instrucciones de manejo
FAQs
Technical Support

Erlotinib lactam impurity (compound 7a) is a precursor of the tyrosine kinase inhibitor.

Para uso exclusivo en investigación. No vendemos a pacientes.

Erlotinib lactam impurity Estructura química

No. CAS : 179688-29-0

Tamaño	Stock	Cantidad
25 g	En stock	Estimated Time of Arrival: December 31
50 g	En stock	Estimated Time of Arrival: December 31
100 g	En stock	Estimated Time of Arrival: December 31
> 100 g	Obtener un presupuesto

or Consulta para venta a granel

* Seleccione Cantidad antes de agregar artículos.

This product is a controlled substance and not for sale in your territory.

Revisión del cliente

Based on 1 Customer Validation

Recomendaciones destacadas

•Related Screening Libraries:

•Related Small Molecules:

•Related Proteins:

Actividad biológica
Pureza y Documentación
Referencias
Revisión del cliente

Descripciòn

Erlotinib lactam impurity (compound 7a) is a precursor of the tyrosine kinase inhibitor^[1].

Peso molecular

294.30

Fòrmula

C₁₄H₁₈N₂O₅

No. CAS

179688-29-0

Appearance

Solid

Color

White to off-white

SMILES

O=C1NC=NC2=C1C=C(C(OCCOC)=C2)OCCOC

Envío

Room temperature in continental US; may vary elsewhere.

Almacenamiento

Powder	-20°C	3 years
	4°C	2 years
In solvent	-80°C	6 months
	-20°C	1 month

Pureza y Documentación

Purity: 98.50%

Select Batch:

Ficha de datos (267 KB) SDS (393 KB)

COA (248 KB) HNMR (117 KB) LCMS (237 KB)

Instrucciones de manejo (2659 KB)

Referencias

[1]. Yann Seimbille, et al. Fluorine-18 labeling of 6,7-disubstituted anilinoquinazoline derivatives for positron emission tomography (PET) imaging of tyrosine kinase receptors: synthesis of 18F-Iressa and related molecular probes. J Label Compd Radiopharm 2005; 48: 829–843.